Chemoinformaics analysis of 2,6,6,9-TETRAMETHYLTRICYCLO[5.4.0.01,5]UNDEC-8-ENE
| Molecular Weight | 204.357 | nRot | 0 |
| Heavy Atom Molecular Weight | 180.165 | nRig | 13 |
| Exact Molecular Weight | 204.188 | nRing | 3 |
| Solubility: LogS | -5.717 | nHRing | 0 |
| Solubility: LogP | 4.989 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
| Atoms Count | 39 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 41.053 |
| nHD | 0 | BPOL | 24.077 |
| QED | 0.513 |
| Synth | 4.819 |
| Natural Product Likeliness | 3.329 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.084 |
| Pgp-sub | 0 |
| HIA | 0.005 |
| CACO-2 | -4.618 |
| MDCK | 0.0000168 |
| BBB | 0.92 |
| PPB | 0.949795 |
| VDSS | 2.652 |
| FU | 0.059738 |
| CYP1A2-inh | 0.388 |
| CYP1A2-sub | 0.353 |
| CYP2c19-inh | 0.272 |
| CYP2c19-sub | 0.913 |
| CYP2c9-inh | 0.425 |
| CYP2c9-sub | 0.609 |
| CYP2d6-inh | 0.022 |
| CYP2d6-sub | 0.571 |
| CYP3a4-inh | 0.089 |
| CYP3a4-sub | 0.299 |
| CL | 12.519 |
| T12 | 0.044 |
| hERG | 0.008 |
| Ames | 0.005 |
| ROA | 0.048 |
| SkinSen | 0.036 |
| Carcinogencity | 0.021 |
| EI | 0.83 |
| Respiratory | 0.935 |
| NR-Aromatase | 0.014 |
| Antiviral | Yes |
| Prediction | 0.914264 |